Breaking News
Get 50% Off 0
50% Off! Beat the market in 2025 with InvestingPro
CLAIM SALE
Close

Candriam Equities L Biotechnology Class I Usd Cap (0P000014AP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5,749.780 +42.330    +0.74%
23/12 - Closed. Currency in USD
  • Morningstar Rating:
  • Total Assets: 1.39B
Type:  Fund
Market:  Luxembourg
Issuer:  Candriam Luxembourg S.C.A.
ISIN:  LU0133360163 
Asset Class:  Equity
Candriam Equities L Biotechnology Class I USD Cap 5,749.780 +42.330 +0.74%

0P000014AP Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Candriam Equities L Biotechnology Class I USD Cap (0P000014AP) fund. Our Candriam Equities L Biotechnology Class I USD Cap portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 4.160 4.200 0.040
Shares 95.840 95.840 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 18.749 19.734
Price to Book 4.458 3.904
Price to Sales 5.995 5.520
Price to Cash Flow 15.257 15.057
Dividend Yield 0.534 0.495
5 Years Earnings Growth 31.812 31.412

Sector Allocation

Name  Net % Category Average
Healthcare 100.000 99.863

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 88

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Amgen US0311621009 6.09 264.49 +0.19%
  Gilead US3755581036 5.63 93.95 +0.59%
  Regeneron Pharma US75886F1075 5.26 714.47 -0.09%
  Vertex US92532F1003 5.07 408.18 +0.72%
  Alnylam US02043Q1076 4.78 243.25 +0.41%
  BioNTech US09075V1026 3.26 114.13 +0.55%
  Eli Lilly US5324571083 2.59 795.67 -0.08%
  Argen-X NL0010832176 2.27 604.60 +1.55%
  Neurocrine US64125C1099 2.13 136.53 -0.34%
  Insmed US4576693075 1.96 70.53 -0.08%

Top Equity Funds by Candriam

  Name Rating Total Assets YTD% 3Y% 10Y%
  Cleome Index USA Equities I USD Acu 3.14B 27.47 10.18 -
  Cleome Index USA Equities Z USD Acc 3.14B 20.26 7.75 12.32
  Cleome Index USA Eq C USD Inc 3.14B 19.36 6.70 -
  Cleome Index USA Eq C USD Acc 3.14B 19.36 6.70 11.13
  LU1864481541 1.59B 4.37 -0.94 -
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P000014AP Comments

Write your thoughts about Candriam Equities L Biotechnology Class I Usd Cap
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email